SAFETY ALERT: Selective Androgen Receptor Modulators (SARMs)
APRIL 25, 2018 UPDATE: CRN Applauds Legislation to Increase Enforcement Against Illegal Products and Promote Consumer Safety
Are you aware of a new category of illegal drugs known as Selective Androgen Receptor Modulators (SARMs)? They’re a dangerous type of performance-enhancing ingredient, with names like “ostarine” and “andarine,” that pose a serious threat to consumer safety, particularly in the bodybuilding and fitness communities.
FDA has issued a warning about the dangers of SARMs. The World Anti-Doping Agency (WADA) has prohibited SARMs—these ingredients can cause professional and collegiate athletes to lose their eligibility. A new study in the Journal of the American Medical Association has identified the prevalence of SARMs in the online marketplace. They’re often marketed as dietary supplements—but don’t be fooled. They’re not legitimate dietary supplements, they’re unapproved drugs. And not only can they cause you to test positive for an illegal substance, they can do serious harm to your health.
Here's what you need to know:
- Selective Androgen Receptor Modulators (SARMs) are dangerous and illegal, and have been found in a number of adulterated products masquerading as “dietary supplements.” SARMs are unapproved drugs, not dietary supplements.
- SARMs pose a risk to all consumers, including athletes, and should be avoided, as they can result in potentially life-threatening consequences.
- SARMs may be listed on the product label (with names like “ostarine” and “andarine”). Or they may not be listed in the ingredients at all. That’s why it’s important to purchase dietary supplements from companies you know and trust—those that don’t make drug-like claims.
- Sports nutrition dietary supplements can play a beneficial role in your workout routine. But keep this in mind: dietary supplements are not intended to have the same immediate or dramatic effects that you would expect from taking a drug. Labels that sound too good to be true, probably are.